Corcept Therapeutics
CORT
#2065
Rank
$9.19 B
Marketcap
$87.30
Share price
-0.78%
Change (1 day)
57.50%
Change (1 year)

Corcept Therapeutics (CORT) Fails to deliver data

Key failure to deliver metrics for Corcept Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Corcept Therapeutics (CORT) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Corcept Therapeutics (CORT) - since 2013

Volume in USD (price x number of shares), data since 2013

Corcept Therapeutics (CORT) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025$25.6 M-24.17%
2024$33.76 M201.09%
2023$11.21 M14.83%
2022$9.76 M-67.39%
2021$29.94 M163.11%
2020$11.38 M-51.05%
2019$23.25 M-56.08%
2018$52.94 M28.02%
2017$41.35 M73.96%
2016$23.77 M330.76%
2015$5.51 M41.23%
2014$3.9 M65.65%
2013$2.35 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
$57.52 M$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$5.67 M$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$19.76 M$75.6 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
$0.29 B$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$29.26 M$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$17.08 M$0.16 B๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$4.91 M$11.36 M๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
$0.51 M$1.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$2.28 M$10.82 M๐Ÿ‡บ๐Ÿ‡ธ USA